tiprankstipranks
BioNexus Gene Lab Corp (BGLC)
NASDAQ:BGLC
US Market
BGLC
BioNexus Gene Lab Corp
RESEARCH TOOLSreports

BioNexus Gene Lab Corp (BGLC) Income Statement

111 Followers

BioNexus Gene Lab Corp Income Statement

Last quarter (Q1 2026), BioNexus Gene Lab Corp's total revenue was $22.84K, a decrease of -98.93% from the same quarter last year. In Q1, BioNexus Gene Lab Corp's net income was $-543.58K. See BioNexus Gene Lab Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 7.42M$ 9.51M$ 9.77M$ 10.93M$ 13.36M
Gross Profit
$ 1.09M$ 1.29M$ 1.33M$ 1.26M$ 2.19M
Operating Expenses
$ 4.24M$ 2.86M$ 3.92M$ 1.55M$ 1.14M
Depreciation and Amortization
$ 168.31K$ 153.14K$ 108.42K$ 105.42K$ 108.22K
EBITDA
$ -2.80M$ -1.42M$ -2.49M$ -185.76K$ 1.16M
Operating Income
$ -3.16M$ -1.57M$ -2.59M$ -291.18K$ 1.06M
Other Income/Expenses
$ 173.84K$ -21.15K$ -13.93K$ -12.48K$ -12.97K
Pretax Income
$ -2.98M$ -1.59M$ -2.61M$ -303.66K$ 1.04M
Net Income
$ -2.98M$ -1.60M$ -2.63M$ -355.97K$ 751.57K
Per Share Metrics
Basic EPS
$ -1.61$ -0.90$ -1.53$ -0.25$ 0.53
Diluted EPS
$ -1.61$ -0.90$ -1.53$ -0.25$ 0.53
Weighted Average Shares Outstanding
 1.86M 1.78M 1.72M 1.44M 1.43M
Weighted Average Shares Outstanding (Diluted)
 1.86M 1.78M 1.72M 1.44M 1.43M
Currency in USD

BioNexus Gene Lab Corp Earnings and Revenue History